NCT00091325已完成1 期
Phase I Drug Interaction Clinical Study of Polyphenon E
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
RATIONALE: Green tea extract (Polyphenon E) contains ingredients that may prevent the development of cancer.
PURPOSE: This phase I trial is studying how well green tea extract works in preventing cancer in healthy participants.
详细描述
OBJECTIVES:
Primary
- Determine the effect of green tea extract (Polyphenon E) on cytochrome P450 enzyme activities and glutathione S-transferase activities and levels in healthy participants.
Secondary
- Determine the safety and tolerability of this drug in these participants.
研究设计
- 研究类型
- Interventional
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
终止
2 期
Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous ConditionNCT00942422Barbara Ann Karmanos Cancer Institute8
已完成
1 期
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaLeukemiaNCT00262743Mayo Clinic73
已完成
1 期
Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & NeckCancer of Head and NeckNeoplasms, Head and NeckNCT01116336Emory University25
已完成
1 期
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the ProstateAdenocarcinoma of the ProstateStage I Prostate CancerStage II Prostate CancerNCT00459407National Cancer Institute (NCI)50
终止
1 期
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung CancerNon-Small Cell Lung CancerNCT00707252Louisiana State University Health Sciences Center Shreveport11